Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decitabine Plus Carboplatin in the Treatment of Metastatic Triple Negative Breast Cancer

NCT03295552 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT03295552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03295552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decitabine Plus Carboplatin in the Treatment of Metastatic Triple Negative Breast Cancer
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
November 15, 2017
Completion date
June 1, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm